Cite
APA Citation
Hao, D., Juergens, R., Laurie, S., Mates, M., Tehfe, M., Bradbury, P., Kollmannsberger, C., Ellis, P., Hilton, J., Brown-Walker, P., & Seymour, L. (n.d.). a Canadian Cancer Trials Group phase IB study of durvalumab with or without tremelimumab + standard platinum-doublet chemotherapy in patients with advanced, incurable solid malignancies (IND.226). European journal of cancer, 69, S95–. http://access.bl.uk/ark:/81055/vdc_100039473424.0x000057